key: cord-0973437-svhwtorf authors: Allen, Rebecca; Wanersdorfer, Karen; Zebley, James; Shapiro, Geoff; Coullahan, Tiffany; Sarani, Babak title: Interhospital Transfer of Critically Ill Patients due to COVID-19 Related Respiratory Failure date: 2020-07-25 journal: Air Med J DOI: 10.1016/j.amj.2020.07.007 sha: 868454e7c515c1004a0aaa22b94fdab88877a215 doc_id: 973437 cord_uid: svhwtorf INTRODUCTION: Interfacility transfer of patients with COVID-19 related acute respiratory failure is high risk due to the severity of respiratory failure and potential for crew exposure. This paper describes a hospital-based transport team's experience with interfacility transport of SARS-CoV-2 positive patients. METHODS: A retrospective study of transports for respiratory failure due to SARS-CoV-2 was performed. All transports were by a single critical care transport team. The team was already trained in advanced mechanical ventilation, blood gas interpretation, and management of shock. Guidance from the Centers of Disease Control was followed regarding use of personal protective equipment (PPE). RESULTS: Twenty patients were enrolled. Average patient age was 47 (standard deviation (SD) 12) years old. Average APACHE II and SOFA scores were 10 (SD 4) and 24 (SD 7), respectively. Average transport distance and time were 18 miles (SD 9) and 25 (SD 11) minutes, respectively. Nineteen patients were intubated, 9 of whom required advanced ventilation. Two patients were transported prone. One patient experienced unintentional extubation upon transfer from the stretcher to the destination facility bed. The patient was re-intubated without event. No crew members contracted SARS-CoV-2 infection. CONCLUSION: Interfacility transfer of severely ill SARS-CoV-2 positive patients is safe and feasible.  Given the prevalence and severity of illness associated with COVID-19 related acute respiratory failure, it is very likely that community hospitals will need to transfer such patients to regional centers capable of providing advanced care, such as ECMO support  Critical care transport team must be familiar with transporting these patients in the prone position since this position has been shown to improve oxygenation in COVID-19 positive patients with respiratory failure  Critical care transport teams must be familiar with advanced modes of ventilation, such as airway pressure release ventilation (APRV), and blood gas interpretation in order to optimize safety during transport of COVID-19 positive patients with respiratory failure  Decontamination procedures must be followed closely, even if this results in prolonged down-time for the transport team, in order to ensure both crew and subsequent patient safety Transport of a critically ill patient requires detailed coordination to ensure the safety of both the patient and the transport team. Smaller and critical access hospitals, as well as standalone emergency departments, often times do not have the capacity or resources to manage critically ill patients, especially in large volumes. Thus, transfer to a larger tertiary care facility is frequently indicated. As well, secondary and tertiary care centers may need to redistribute patients based on available resources and the ability to manage patients that would typically be available but are not due to the medical surge. In the wake of the SARS-CoV-2 outbreak, there has been an influx of patients requiring complex critical care such as advanced mechanical ventilation and extracorporeal membrane oxygenation (ECMO Transport of the critically ill patient represents a logistical challenge for patient care and is not without inherent risk. One study reported that as many as 68% of transports experienced "unexpected events" and 9% had "serious unexpected events". These serious events included hypotension, the need for intubation, and increased intracranial pressure 4 . These data demonstrate the need for a careful planning and a decision-making process to ensure appropriate care of critically-ill patients during transport. They also show the importance of having dedicated and well-trained transport teams with proper equipment and medical oversight. When caring for patients with infectious diseases, the transport team is also exposed to the additional risk of disease transmission. Studies have shown that prehospital personnel are at especially high risk of exposure, in part due to suboptimal adherence to universal precaution recommendations 56 . The purpose of this manuscript is to describe methods used by the critical care transport team of a quaternary care hospital to safely transfer COVID-19 positive patients with severe respiratory failure to a higher level of care. The aim is to offer solutions to other agencies who may be tasked with transporting similarly ill patients, both during the current pandemic as well as possible future ones. This study is a retrospective review of patients who were transported from outlying hospitals to a regional referral center by a hospital based Critical Care Transport Team (CCT). This team was established in January 2018 and consists of a critical care transport nurse, critical care paramedic, and emergency medical technician. All team members have received additional training as noted in table 1 and are overseen by a dedicated medical director. The team utilizes the Hamilton Medical T-1 portable ventilator, which has the ability to provide airway pressure release ventilation (APRV), and carries the majority of standard medications used to manage critically ill patients. After obtaining approval from the IRB, the transport logs and medical records of all consecutive COVID-19 positive patients who were transported from an outlying facility by the CCT from March 1, 2020 to May 31, 2020 were abstracted. Only patients who were confirmed to be infected by the SARS-CoV-2 virus were enrolled. The referring facility was not contacted for additional information that was not available in the receiving facility's medical record. The transport team was instructed to wear eye protection, impervious gown, 2 pairs of gloves, and a fitted N-95 mask for each transport and was asked to self-monitor for signs or symptoms of COVID-19 after they completed transfers. This involved twice daily temperature checks and self-reporting of symptoms suggestive of COVID-19 infection. The ambulance was decontaminated with an ammonium chloride and chlorine dioxide (Vital Oxide RTU™) virucidal fogging agent after each transport. Personal hygiene practices were emphasized. The CCT carried out 154 transports during the study period. Of this number, a total of 20 COVID-19 positive patient transports were completed and constitute the study cohort. All transports originated from within the District of Columbia, Virginia, or Maryland and terminated in Washington, DC. The average distance travelled by the transport team was 17.95 (standard deviation (SD) 8.5) miles and the average transport time 25 (SD 11) minutes. Only one transport required the medical director to accompany the team, but no intervention was required by the physician. The decision to accompany the team was made by the medical director as this was the first time that the CCT had to transport an intubated patient in the prone position. Overall, 18 patients were transported supine and two were transported prone during the study period. Six (30%) of the transports necessitated real-time guidance and/or orders from the medical director as compared to 81/1402 (6%) transports in the 24 months prior to the COVID-19 pandemic. Nearly all guidance requested was related to advanced mechanical ventilation for severe hypoxic respiratory failure. Frequently medical control was sought due to concomitant severe hypotension and hypoxemia despite pre-existing vasopressors and high ventilator settings. The average age of the patients was 47 (SD 12) years old and 14 (70%) were male. The majority were Hispanic (n=11, 55%) and the remainder were African American (n=7, 35%) and Caucasian (n=2, 10%). Length of stay at the outside facility prior to transfer averaged 5.5 (SD 3.5) days. The reason for transfer included ECMO evaluation (n=14, 70%) and lack of ICU bed availability at the referring hospital (n=6, 30%). Paralytics were utilized prior to transport in 8 (40%) patients and 5 (25%) patients had continuous paralytic infusion during the transport. Vasopressors were necessary prior to transport in 8 (40%) patients and were initiated during the transport in 9 (45%) patients. The most commonly used vasopressor was norepinephrine, which was used in 6 patients prior to transport and in 7 patients during transport. The average dose noted prior to transport was 8 (SD 4) micrograms/minute, whereas the average dose during transport was increased by the crew to 13 (SD 9) micrograms/minute. One patient required concomitant vasopressin infusion at 0.04 units/hour prior to transport and 0.08 units/hour during transport. Epinephrine was utilized for two patients at an average dose of 8 (SD 4) micrograms/minute prior to transport and 12 (SD 2) micrograms/minute during transport. Vasopressin infusion was used alone in 6 patients (30%) prior to transport. This infusion was stopped by the CCT prior to transport as it was deemed to not be necessary to maintain an adequate blood pressure. One patient required concomitant support with epinephrine, norepinephrine, phenylephrine, and vasopressin. Patients were sedated during the transport using a combination of propofol (n=6, 30%), opioid (n=8, 40%), dexmedetomidine (n=1, 5%), and benzodiazepines (n=5, 25%). Prior to transfer, 9 patients (45%) were being ventilated using a volume control There was one adverse event involving inadvertent extubation while transferring a patient from the ambulance to the destination ICU bed. This was immediately recognized and the patient was reintubated without event by the receiving ICU team. Two patients died within 24 hours of transport due to their disease. No team members contracted COVID-19 and there were no other adverse events noted. The COVID-19 pandemic has forced healthcare providers to confront new problems and the transportation of critically ill patients between facilities is no exception. This is the first study to report on interhospital transfer of COVID-19 positive patients with severe, acute, hypoxic respiratory failure. All but one patient required mechanical ventilation and nearly half required vasopressor support. We found no evidence of transmission of SARS-CoV-2 from the patient to the transport team and there was only one patient-associated adverse event noted with no longterm sequelae. There were also no instances of patient deterioration due to transport. Prior to the COVID-19 pandemic, the CCT team had been trained on the principles of advanced mechanical ventilation, including APRV, and blood gas interpretation/acid-base physiology. Prior to the COVID-19 pandemic, approximately 18% of their transports involved a patient who was intubated. As such, the CCT was familiar with ventilator adjustment and movement of patients who are mechanically ventilated. This training was pivotal in their ability to transport patients with COVID-19 related acute respiratory failure. In regards to prone positioning, the entire CCT team underwent "just-in-time" training by the ICU nursing staff, who have utilized prone positioning for many years for hypoxic respiratory failure. Specific points of education included how to position tubes and lines to ensure safety during the actual turn, how to pad pressure points to prevent pressure ulcers during transport, and how to assess for unintentional extubation upon completion of the turn. In addition to the CCT, the medical director also underwent this training. The back of an ambulance can be a disruptive environment, with frequent turns and uneven surfaces. Transporting intubated patients requires persistent vigilance to ensure the endotracheal tube does not become dislodged. This problem is well-recognized and can have disastrous consequences if not recognized immediately 7 . While the vast majority of patients were transported in the supine position, two required prone transport due to hypoxic respiratory failure that was refractory to conventional therapy. Both patients had already been placed prone at the referring facility for this reason. Transporting patients prone has been previously demonstrated as a safe technique in small patient studies 8 . Although air transport may allow for faster transport speed, ground transport offers the advantage of greater access to the patient for interventions. It is also possible to stop the ambulance as needed to carry out procedures, which is especially relevant in transporting patients in the prone position. If an event had occurred where providers needed to supinate the patient and/or carry out procedures (e.g. re-intubation), they would have been able to stop the ambulance and attend to the patient. This allowed a greater degree of confidence in quickly altering the CCT's protocols to allow for prone transports. Lack of proper disinfection technique of the ambulance can lead to exposure of both the crew and subsequent patients to pathogens. This becomes particularly important when the patients being transported have a highly communicable disease and even more so when that disease has no currently proven efficacious treatment. Available evidence demonstrates that SARS-CoV-2 can survive on various surfaces with viable virus noted up to 72 hours 9 . The virus survives longest on steel and plastic surfaces, both of which are commonly found in ambulances. We therefore opted to decontaminate the ambulance after each COVID-19 positive transport with a fogging solution. Although this resulted in the unit being removed from service for at least one hour after each transport, CCT leadership felt that this was needed to assure crew safety and continuity of operations. No transports were delayed or canceled as a result of the unit being out of service. Of note, the ambulance could be used for back-to-back COVID-19 related transports without being terminally cleaned, but such an event did not occur during the study period. We were also fortunate to have an ample supply of PPE and utilized accepted practices and protocols for PPE preservation. This study has several limitations which we acknowledge. It is a retrospective study which limited our ability to obtain clinical information on patient status prior to their transport. Although there was only one adverse event noted, the small sample size precludes us from being able to confidently comment on the safety of these high risk transports. Future larger studies are needed to assess safety. Although we assessed final patient disposition, we did not assess daily changes in clinical status given that the study design was focused on the transport itself rather than outcomes associated with COVID-19 respiratory failure. A properly equipped, well-trained transport team can provide safe interhospital transfer of critically ill patients without compromising either patient or team safety. This investigation into our experience transporting severely-ill patients who tested positive for COVID-19 serves to demonstrate the importance of maintaining this resource. Health-system based transport teams provide an important logistical connection between where patients present and where they may need to be in order to receive the most appropriate care. As such, quaternary hospitals should invest in such systems as part of their mission to support community hospitals within their region and ultimately optimize health outcomes for their patients. Disclosure of Interest: The authors report no conflict of interest Funding source: None Data availability: Data are available for review upon request Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis -PubMed Clinical Characteristics of Coronavirus Disease Unexpected Events during the Intrahospital Transport of Critically Ill Patients EMS provider compliance with infection control recommendations is suboptimal Hand hygiene in emergency medical services Preliminary experience with a prospective, multi-centered evaluation of out-of-hospital endotracheal intubation Transport of Mechanically Ventilated Patients in the Prone Position Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1